A FISH test (fluorescence in situ hybridization) is a laboratory technique that detects specific DNA sequences on your chromosomes using fluorescent probes. It’s used to diagnose genetic conditions, identify certain cancers, and screen for chromosomal abnormalities during pregnancy. Results typically come back within a few days, making it faster than many other genetic tests.
How FISH Testing Works
The basic concept is surprisingly elegant. A sample of your cells, whether from blood, bone marrow, or tissue, is placed on a glass slide. Scientists then apply a “probe,” which is a small piece of manufactured DNA tagged with a fluorescent dye. This probe is designed to match one specific DNA sequence. When the probe finds its target sequence on your chromosomes, it locks onto it like a puzzle piece snapping into place.
Under a special fluorescent microscope, the probe lights up wherever it has attached. This lets technicians see exactly where on a chromosome a particular gene sits, whether it’s been duplicated, deleted, or swapped to a different chromosome entirely. The color, number, and position of the glowing signals tell the story. Two signals where there should be one suggests a duplication. A missing signal points to a deletion. Signals on the wrong chromosomes indicate a translocation, where pieces of DNA have broken off and reattached in the wrong location.
What FISH Testing Detects
FISH is versatile enough to answer several different clinical questions depending on the probe used and the condition being investigated. It provides information on both the copy number of a chromosomal region and its location, revealing structural rearrangements like inversions or translocations.
The most common uses fall into three categories:
- Cancer diagnosis and monitoring. FISH can identify genetic changes that drive specific cancers, helping doctors choose targeted treatments and track whether therapy is working.
- Prenatal screening. During pregnancy, FISH can rapidly assess five chromosomes (21, 18, 13, X, and Y) to check for conditions like Down syndrome, Edwards syndrome, and Patau syndrome.
- Genetic disorders. FISH detects deletions or duplications linked to inherited conditions. For example, it can identify a missing segment of the gene responsible for Duchenne muscular dystrophy by showing one chromosome with an absent probe signal.
FISH in Cancer Care
One of the most well-known applications is in breast cancer, where FISH helps determine whether a tumor has extra copies of the HER2 gene. HER2-positive cancers tend to be more aggressive, but they also respond to specific targeted therapies. When an initial screening test comes back equivocal (scored as 2+), FISH is used as a follow-up to give a definitive answer. That result directly shapes which treatments a patient is offered.
In blood cancers, FISH plays a critical role in detecting the Philadelphia chromosome, a hallmark of chronic myeloid leukemia. This abnormality forms when pieces of chromosomes 9 and 22 break off and swap places, creating an abnormal fusion gene that drives cancer cell growth. FISH can spot this rearrangement in individual cells without needing to culture them first, which speeds up diagnosis considerably. Beyond the initial diagnosis, repeated FISH testing tracks treatment response over time. If the number of cells carrying the abnormal gene decreases, treatment is working. If it increases, the cancer may be resistant or returning.
How Long Results Take
Turnaround time depends on what’s being tested. Simple chromosome counting (aneuploidy screening, often done prenatally) comes back in one to three days. Cancer-related FISH studies typically take two to seven days. More complex analyses looking for small deletions or duplications can take one to two weeks. Some tests require growing cells in the lab before analysis can begin, which adds variability to the timeline.
This speed is one of FISH’s practical advantages over traditional chromosome analysis (karyotyping), which often requires longer cell culture periods. FISH extends the capabilities of standard chromosome banding by resolving ambiguous results and catching abnormalities too small for conventional methods to see.
Strengths and Limitations
FISH is highly targeted, which is both its greatest strength and its main limitation. Because each probe is designed for a specific DNA sequence, the test is excellent at answering focused questions: Is this gene deleted? Is this chromosome duplicated? Has this translocation occurred? It can be performed on preserved tissue samples from tumors without needing living cells, which makes it practical in many clinical settings.
The tradeoff is that FISH only finds what you’re looking for. It won’t scan the entire genome for unexpected problems. If doctors suspect a particular genetic change, FISH is fast and precise. If the question is more open-ended, broader tests like chromosomal microarray or whole-genome sequencing are better suited. Newer technologies can detect abnormalities below the resolution limits of FISH, picking up changes too small for even a fluorescent probe to flag.
Accuracy varies by context. In some applications, FISH is extremely reliable. In others, sensitivity can be moderate. For biliary strictures (a narrowing in the bile ducts), for instance, a meta-analysis of 18 studies found FISH had an overall sensitivity of about 58% and specificity of 88%, meaning it’s better at confirming a diagnosis than ruling one out. In well-established applications like HER2 testing or Philadelphia chromosome detection, performance is considerably stronger because the targets are well characterized and the probes are highly refined.
What the Experience Looks Like
From your perspective as a patient, a FISH test doesn’t involve a separate procedure in most cases. The sample is collected during a blood draw, bone marrow biopsy, amniocentesis, or tissue biopsy that’s already being done for other reasons. The FISH analysis happens in the lab afterward. You won’t feel anything different from the sample collection itself.
Your results will typically describe whether the target genetic change was detected or not. In cancer monitoring, results may describe your response as minor, partial, major, or complete based on how many abnormal cells remain. Your doctor uses these results alongside other tests to build a complete picture, since FISH answers one specific question at a time rather than providing a comprehensive genetic profile.